{"DataElement":{"publicId":"14616759","version":"1","preferredName":"PDX Tumor Origin Evaluated Type","preferredDefinition":"The source of the PDX tumor.","longName":"14616476v1.00:14616737v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"14616476","version":"1","preferredName":"Patient Derived Xenograft Neoplasm Origin Evaluation","preferredDefinition":"A mouse model for human cancer studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"14596168v1.00:14616477v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"14596168","version":"1","preferredName":"Patient Derived Xenograft","preferredDefinition":"A mouse model for human cancer studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse.","longName":"C122936","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient Derived Xenograft","conceptCode":"C122936","definition":"A mouse model for human cancer studies in which a human-derived tumor sample is transplanted into an immunodeficient mouse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"092E431B-30AD-4333-E063-731AD00AD768","latestVersionIndicator":"Yes","beginDate":"2023-11-02","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-11-02","modifiedBy":"FINCHAMB","dateModified":"2023-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14616477","version":"1","preferredName":"Neoplasm Origin Evaluation","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"C3262:C42703:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Origin","conceptCode":"C42703","definition":"The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AAF1E70-67D5-3305-E063-731AD00A2404","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0AAF15C0-882B-31CF-E063-731AD00A1CDC","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":"11/21/23 Created per CCDI submission template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14616737","version":"1","preferredName":"Tumor Origin Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Something distinguishable as an identifiable class based on common qualities.","longName":"14616737v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mouse","valueDescription":null,"ValueMeaning":{"publicId":"2578400","version":"1","preferredName":"Mouse","longName":"2578400","preferredDefinition":"Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mouse","conceptCode":"C14238","definition":"Any of numerous species of small rodents belonging to the genus Mus and various related genera of the family Muridae.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF4D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-24","endDate":null,"createdBy":"HARDINGR","dateCreated":"2006-03-24","modifiedBy":"CURTIST","dateModified":"2007-03-29","changeDescription":"03/29/2007 - Updated with NCI Thesaurus definition and concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0AAF4263-2902-3972-E063-731AD00AEEBC","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","deletedIndicator":"No"},{"value":"EBV","valueDescription":null,"ValueMeaning":{"publicId":"5527882","version":"1","preferredName":"Epstein-Barr Virus","longName":"5527882","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4C6595-C88A-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0AAF4263-2903-3972-E063-731AD00AEEBC","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","deletedIndicator":"No"},{"value":"Neither","valueDescription":null,"ValueMeaning":{"publicId":"14616758","version":"1","preferredName":"Neither","longName":"14616758v1.00","preferredDefinition":"Not either one; not the one or the other.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neither","conceptCode":"C126390","definition":"Not either one; not the one or the other.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AAF4263-2901-3972-E063-731AD00AEEBC","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0AAF4263-2904-3972-E063-731AD00AEEBC","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14616736","version":"1","preferredName":"Neoplasm Origin Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The place where something begins or comes from in either the sense of a physical location or a metaphysical source._Something distinguishable as an identifiable class based on common qualities.","longName":"14616736v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Origin","conceptCode":"C42703","definition":"The place where something begins or comes from in either the sense of a physical location or a metaphysical source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0AAF2877-760C-349C-E063-731AD00ACF4B","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0AAF2877-760D-349C-E063-731AD00ACF4B","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":"11/21/23 Created per CCDI submission template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594093","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596046","version":"1","longName":"PDX","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"tumor_not_mus_or_ebv_origin","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"PDX Tumor Origin","url":null,"context":"Pediatric Cancer"}],"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0AAF4A0A-09A9-3AFA-E063-731AD00A6387","latestVersionIndicator":"Yes","beginDate":"2023-11-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-11-21","modifiedBy":"COLBERTM","dateModified":"2023-11-21","changeDescription":null,"administrativeNotes":"11/21/23 Created per CCDI submission template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}